Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

COVID-2019 infections vaccine - Generex Biotechnology

Next Previous
Drug Profile

COVID-2019 infections vaccine - Generex Biotechnology

Alternative Names: 'Ii-Key-nCOV peptide vaccine - Generex Biotechnology; Complete Vaccine™ - Generex Biotechnology; Coronavirus vaccine - Generex Biotechnology; Ii-Key-SARS-CoV-2 vaccine; SARS-CoV-2 virus vaccines - Generex Biotechnology

Latest Information Update: 28 Jan 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Generex Biotechnology Corporation
  • Class COVID-19 vaccines; Peptide vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • No development reported COVID 2019 infections

Most Recent Events

  • 28 Jan 2025 No recent reports of development identified for preclinical development in COVID-2019-infections(Prevention) in USA (Parenteral)
  • 28 Apr 2024 No recent reports of development identified for research development in COVID-2019-infections(Prevention) in China (Parenteral)
  • 27 Apr 2021 Generex Biotechnology Corporation announces intention to submit IND application to National Medical Products Administration (NMPA) for COVID-2019 infections

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top